{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:43:17Z","timestamp":1790210597788,"version":"4.1.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>Humoral immunity is a major waypoint towards chronic allograft dysfunction in lung transplantation (LT) recipients. Though allo-immunization and antibody-mediated rejection (AMR) are well-known entities, some diagnostic gaps need to be addressed. Morphological analysis could be enhanced by digital pathology and artificial intelligence-based companion tools. Graft transcriptomics can help to identify graft failure phenotypes or endotypes. Donor-derived cell free DNA is being evaluated for graft-loss risk stratification and tailored surveillance. Preventative therapies should be tailored according to risk. The donor pool can be enlarged for candidates with HLA sensitization, with strategies combining plasma exchange, intravenous immunoglobulin and immune cell depletion, or with emerging or innovative therapies such as imlifidase or immunoadsorption. In cases of insufficient pre-transplant desensitization, the effects of antibodies on the allograft can be prevented by targeting the complement cascade, although evidence for this strategy in LT is limited. In LT recipients with a humoral response, strategies are combined, including depletion of immune cells (plasmapheresis or immunoadsorption), inhibition of immune pathways, or modulation of the inflammatory cascade, which can be achieved with photopheresis. Altogether, these innovative techniques offer promising perspectives for LT recipients and shape the 21st century\u2019s armamentarium against AMR.<\/jats:p>","DOI":"10.3389\/ti.2024.12973","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:57:13Z","timestamp":1723006633000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Antibody-Mediated Rejection in Lung Transplantation: Diagnosis and Therapeutic Armamentarium in a 21st Century Perspective"],"prefix":"10.3389","volume":"37","author":[{"given":"Jonathan","family":"Messika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Belousova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Parquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/ajt.13589","article-title":"Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody Characteristics","volume":"16","author":"Roux","year":"2016","journal-title":"Am J Transpl"},{"key":"B2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/TP.0b013e31827afb0f","article-title":"Lung Transplantation in Patients With Pretransplantation Donor-Specific Antibodies Detected by Luminex Assay","volume":"95","author":"Brugi\u00e8re","year":"2013","journal-title":"Transplantation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.athoracsur.2008.02.011","article-title":"Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients","volume":"85","author":"Shah","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1164\/rccm.201509-1857OC","article-title":"De Novo DQ Donor-Specific Antibodies Are Associated With Chronic Lung Allograft Dysfunction After Lung Transplantation","volume":"194","author":"Tikkanen","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.healun.2018.01.1305","article-title":"Late Manifestation of Alloantibody-Associated Injury and Clinical Pulmonary Antibody-Mediated Rejection: Evidence From Cell-Free DNA Analysis","volume":"37","author":"Agbor-Enoh","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"B6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.healun.2022.09.012","article-title":"Clinical Features and Allograft Failure Rates of Pulmonary Antibody-Mediated Rejection Categories","volume":"42","author":"Charya","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"B7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the Positive Crossmatch Test in Kidney Transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1378\/chest.110.2.559","article-title":"Hyperacute Rejection Following Lung Transplantation","volume":"110","author":"Frost","year":"1996","journal-title":"Chest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.healun.2010.01.012","article-title":"Antibody-Mediated Rejection in Lung Transplantation: Myth or Reality?","volume":"29","author":"Glanville","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1097\/00007890-200211150-00013","article-title":"Humorally Mediated Posttransplantation Septal Capillary Injury Syndrome as a Common Form of Pulmonary Allograft Rejection: A Hypothesis","volume":"74","author":"Magro","year":"2002","journal-title":"Transplantation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.healun.2003.08.030","article-title":"HLA-Specific Antibodies Are Associated With High-Grade and Persistent-Recurrent Lung Allograft Acute Rejection","volume":"23","author":"Girnita","year":"2004","journal-title":"J Heart Lung Transpl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1600-6143.2008.02467.x","article-title":"Pulmonary Capillaritis as a Manifestation of Acute Humoral Allograft Rejection Following Infant Lung Transplantation","volume":"9","author":"Astor","year":"2009","journal-title":"Am J Transpl"},{"key":"B13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.healun.2008.09.013","article-title":"Acute Antibody-Mediated Rejection After Lung Transplantation","volume":"28","author":"Morrell","year":"2009","journal-title":"J Heart Lung Transpl"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung Rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transpl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-Mediated Rejection of the Lung: A Consensus Report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"B16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s13244-018-0647-9","article-title":"Radiological Findings of Complications After Lung Transplantation","volume":"9","author":"Habre","year":"2018","journal-title":"Insights Imaging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1148\/rg.274065141","article-title":"Postoperative Complications of Lung Transplantation: Radiologic Findings Along a Time Continuum","volume":"27","author":"Krishnam","year":"2007","journal-title":"Radiographics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2101652","DOI":"10.1183\/13993003.01652-2021","article-title":"Chronic Lung Allograft Dysfunction Phenotype and Prognosis by Machine Learning CT Analysis","volume":"60","author":"McInnis","year":"2022","journal-title":"Eur Respir J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/TP.0000000000002058","article-title":"Gene Expression Profiling of Bronchoalveolar Lavage Cells During Aspergillus Colonization of the Lung Allograft","volume":"102","author":"Weigt","year":"2018","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transpl"},{"key":"B21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.trre.2013.07.001","article-title":"Interpretation of HLA Single Antigen Bead Assays","volume":"27","author":"Ellis","year":"2013","journal-title":"Transpl Rev (Orlando)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/tri.13149","article-title":"Donor-Specific HLA Antibody-Mediated Complement Activation Is a Significant Indicator of Antibody-Mediated Rejection and Poor Long-Term Graft Outcome During Lung Transplantation: A Single Center Cohort Study","volume":"31","author":"Roux","year":"2018","journal-title":"Transpl Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1701898","DOI":"10.1183\/13993003.01898-2017","article-title":"Role of C1q-Binding Anti-HLA Antibodies as a Predictor of Lung Allograft Outcome","volume":"52","author":"Brugi\u00e8re","year":"2018","journal-title":"Eur Respir J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1111\/ajt.14939","article-title":"Comparison of De Novo IgM and IgG Anti-HLA DSAs Between Belatacept- and Calcineurin-Treated Patients: An Analysis of the BENEFIT and BENEFIT-EXT Trial Cohorts","volume":"18","author":"Everly","year":"2018","journal-title":"Am J Transpl"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transpl"},{"key":"B27","doi-asserted-by":"publisher","first-page":"101904","DOI":"10.1016\/j.trim.2023.101904","article-title":"Preemptive Immune Globulin Therapy in Sensitized Lung Transplant Recipients","volume":"80","author":"Goldsby","year":"2023","journal-title":"Transpl Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1378\/chest.12-0587","article-title":"Implications for Human Leukocyte Antigen Antibodies After Lung Transplantation: A 10-Year Experience in 441 Patients","volume":"144","author":"Snyder","year":"2013","journal-title":"Chest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"S249","DOI":"10.1016\/j.healun.2004.06.022","article-title":"Pre-Transplant Panel Reactive Antibody in Lung Transplant Recipients Is Associated With Significantly Worse Post-Transplant Survival in a Multicenter Study","volume":"24","author":"Hadjiliadis","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.healun.2016.06.010","article-title":"Lung Intragraft Donor-Specific Antibodies as a Risk Factor for Graft Loss","volume":"35","author":"Visentin","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1900847","DOI":"10.1183\/13993003.00847-2019","article-title":"Intragraft Donor-Specific Anti-HLA Antibodies in Phenotypes of Chronic Lung Allograft Dysfunction","volume":"54","author":"Sacreas","year":"2019","journal-title":"Eur Respir J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e13906","DOI":"10.1111\/ctr.13906","article-title":"The Shared Epitope Phenomenon-A Potential Impediment to Virtual Crossmatch Accuracy","volume":"34","author":"Garcia-Sanchez","year":"2020","journal-title":"Clin Transpl"},{"key":"B33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.healun.2023.12.007","article-title":"Chronic Lung Allograft Dysfunction Is Associated With an Increased Number of Non-HLA Antibodies","author":"Xu","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/j.athoracsur.2016.03.042","article-title":"Humoral Human Lung Allograft Rejection by Tissue-Restricted Non-HLA Antibodies","volume":"102","author":"Fernandez","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.31486\/toj.17.0068","article-title":"Non-Human Leukocyte Antigen Antibody-Mediated Lung Transplant Rejection: The Other Anti-A","volume":"18","author":"Vinson","year":"2018","journal-title":"Ochsner J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/ajt.14053","article-title":"Immediate and Catastrophic Antibody-Mediated Rejection in a Lung Transplant Recipient With Anti-Angiotensin II Receptor Type 1 and Anti-Endothelin-1 Receptor Type A Antibodies","volume":"17","author":"Cozzi","year":"2017","journal-title":"Am J Transpl"},{"key":"B37","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S0140-6736(18)32473-5","article-title":"Contribution of Non-HLA Incompatibility Between Donor and Recipient to Kidney Allograft Survival: Genome-Wide Analysis in a Prospective Cohort","volume":"393","author":"Reindl-Schwaighofer","year":"2019","journal-title":"Lancet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1002572","DOI":"10.1371\/journal.pmed.1002572","article-title":"Complement-Activating Donor-Specific Anti-HLA Antibodies and Solid Organ Transplant Survival: A Systematic Review and Meta-Analysis","volume":"15","author":"Bouquegneau","year":"2018","journal-title":"Plos Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/ajt.14534","article-title":"The Role of C4d Deposition in the Diagnosis of Antibody-Mediated Rejection After Lung Transplantation","volume":"18","author":"Aguilar","year":"2018","journal-title":"Am J Transpl"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.healun.2014.06.006","article-title":"Reproducibility of Complement 4d Deposition by Immunofluorescence and Immunohistochemistry in Lung Allograft Biopsies","volume":"33","author":"Roden","year":"2014","journal-title":"J Heart Lung Transpl"},{"key":"B41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MOT.0000000000000040","article-title":"Antibody-Mediated Graft Injury: Complement-Dependent and Complement-Independent Mechanisms","volume":"19","author":"Valenzuela","year":"2014","journal-title":"Curr Opin Organ Transpl"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1097\/TP.0000000000002717","article-title":"Update on C1 Esterase Inhibitor in Human Solid Organ Transplantation","volume":"103","author":"Berger","year":"2019","journal-title":"Transplantation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1902027","DOI":"10.1183\/13993003.02027-2019","article-title":"C1-Esterase Inhibitor Treatment for Antibody-Mediated Rejection After Lung Transplantation: Two Case Reports","volume":"55","author":"Parquin","year":"2020","journal-title":"Eur Respir J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1681\/ASN.2017050589","article-title":"Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment","volume":"29","author":"Lefaucheur","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.healun.2015.08.021","article-title":"Banff Study of Pathologic Changes in Lung Allograft Biopsy Specimens With Donor-Specific Antibodies","volume":"35","author":"Wallace","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"B46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1600-6143.2010.03382.x","article-title":"Pathologic Interpretation of Transbronchial Biopsy for Acute Rejection of Lung Allograft Is Highly Variable","volume":"11","author":"Arcasoy","year":"2011","journal-title":"Am J Transpl"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.healun.2022.06.021","article-title":"Lung Allograft Standardized Histological Analysis (LASHA) Template: A Research Consensus Proposal","volume":"41","author":"Calabrese","year":"2022","journal-title":"J Heart Lung Transpl"},{"key":"B48","doi-asserted-by":"publisher","first-page":"10393","DOI":"10.1038\/s41598-018-27707-4","article-title":"Comprehensive Analysis of Lung Cancer Pathology Images to Discover Tumor Shape and Boundary Features That Predict Survival Outcome","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1001\/jama.2017.14585","article-title":"Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer","volume":"318","author":"Ehteshami","year":"2017","journal-title":"JAMA"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/bioengineering10091041","article-title":"Artificial Intelligence Advances in Transplant Pathology","volume":"10","author":"Rahman","year":"2023","journal-title":"Bioengineering"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S501","DOI":"10.1016\/j.healun.2020.01.100","article-title":"Detecting Acute Cellular Rejection in Lung Transplant Biopsies by Artificial Intelligence: A Novel Deep Learning Approach","volume":"39","author":"Davis","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.healun.2023.10.002","article-title":"Assessing the Role of Phosphorylated S6 Ribosomal Protein in the Pathological Diagnosis of Pulmonary Antibody-Mediated Rejection","author":"Lunardi","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"B53","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/ajt.15685","article-title":"Molecular Phenotyping of Rejection-Related Changes in Mucosal Biopsies From Lung Transplants","volume":"20","author":"Halloran","year":"2019","journal-title":"Am J Transpl"},{"key":"B54","doi-asserted-by":"publisher","first-page":"11710","DOI":"10.3389\/ti.2023.11710","article-title":"Banff Human Organ Transplant Consensus Gene Panel for the Detection of Antibody Mediated Rejection in Heart Allograft Biopsies","volume":"36","author":"Giarraputo","year":"2023","journal-title":"Transpl Int"},{"key":"B55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ajt.14990","article-title":"Banff Lung Report: Current Knowledge and Future Research Perspectives for Diagnosis and Treatment of Pulmonary Antibody-Mediated Rejection (AMR)","volume":"19","author":"Roux","year":"2019","journal-title":"Am J Transpl"},{"key":"B56","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.healun.2021.04.009","article-title":"Donor-Derived Cell-Free DNA Accurately Detects Acute Rejection in Lung Transplant Patients, a Multicenter Cohort Study","volume":"40","author":"Jang","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1164\/rccm.202305-0798OC","article-title":"Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial","volume":"209","author":"Keller","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.healun.2016.05.020","article-title":"De-Novo Donor-Specific Anti-HLA Antibodies 30 Days After Lung Transplantation Are Associated With a Worse Outcome","volume":"35","author":"Le Pavec","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.healun.2015.06.003","article-title":"The Impact of Pre-Transplant Allosensitization on Outcomes After Lung Transplantation","volume":"34","author":"Bosanquet","year":"2015","journal-title":"J Heart Lung Transpl"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1513\/AnnalsATS.201812-869OC","article-title":"Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies","volume":"16","author":"Courtwright","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"B61","doi-asserted-by":"publisher","first-page":"383","DOI":"10.12659\/AOT.915769","article-title":"Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates","volume":"24","author":"Aversa","year":"2019","journal-title":"Ann Transpl"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2004090","DOI":"10.1183\/13993003.04090-2020","article-title":"A Virtual Crossmatch-Based Strategy for Perioperative Desensitisation in Lung Transplant Recipients With Pre-Formed Donor-Specific Antibodies: 3-Year Outcome","volume":"58","author":"Parquin","year":"2021","journal-title":"Eur Respir J"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1111\/ajt.16707","article-title":"Long-Term Outcomes of Sensitized Lung Transplant Recipients After Peri-Operative Desensitization","volume":"21","author":"Aversa","year":"2021","journal-title":"Am J Transplant"},{"key":"B64","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/ajt.12636","article-title":"Antibody Desensitization Therapy in Highly Sensitized Lung Transplant Candidates","volume":"14","author":"Snyder","year":"2014","journal-title":"Am J Transpl"},{"key":"B65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/ajt.13076","article-title":"Survival in Sensitized Lung Transplant Recipients With Perioperative Desensitization","volume":"15","author":"Tinckam","year":"2015","journal-title":"Am J Transpl"},{"key":"B66","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ajt.2022.11.025","article-title":"First Use of Imlifidase Desensitization in a Highly Sensitized Lung Transplant Candidate: A Case Report","volume":"23","author":"Roux","year":"2023","journal-title":"Am J Transplant"},{"key":"B67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.humimm.2022.10.006","article-title":"Point-Counterpoint: Desensitization to Improve the Likelihood of Lung Transplantation","volume":"84","author":"Roux","year":"2023","journal-title":"Hum Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.healun.2023.10.003","article-title":"Impact of Intraoperative Therapeutic Plasma Exchange on Bleeding in Lung Transplantation","author":"Saddoughi","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"B69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jca.21265","article-title":"The Selective Therapeutic Apheresis Procedures","volume":"28","author":"Sanchez","year":"2013","journal-title":"J Clin Apher"},{"key":"B70","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.humimm.2005.01.025","article-title":"Utility of Peritransplant and Rescue Intravenous Immunoglobulin and Extracorporeal Immunoadsorption in Lung Transplant Recipients Sensitized to HLA Antigens","volume":"66","author":"Appel","year":"2005","journal-title":"Hum Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-Incompatible Kidney Recipients and Survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e2635","DOI":"10.1097\/MD.0000000000002635","article-title":"Desensitization Using Bortezomib and High-Dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation","volume":"95","author":"Jeong","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.healun.2010.05.006","article-title":"Anti-Human Leukocyte Antigen Antibodies and Preemptive Antibody-Directed Therapy After Lung Transplantation","volume":"29","author":"Hachem","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1111\/ajt.14912","article-title":"Preemptive Treatment of Early Donor-Specific Antibodies With IgA- and IgM-Enriched Intravenous Human Immunoglobulins in Lung Transplantation","volume":"18","author":"Ius","year":"2018","journal-title":"Am J Transpl"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e13285","DOI":"10.1111\/ctr.13285","article-title":"Evaluation of Current Strategies for Surveillance and Management of Donor-Specific Antibodies: Single-Center Study","volume":"32","author":"Sullivan","year":"2018","journal-title":"Clin Transpl"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12886","article-title":"Antibody Depletion Strategy for the Treatment of Suspected Antibody-Mediated Rejection In Lung Transplant Recipients: Does It Work?","volume":"31","author":"Vacha","year":"2017","journal-title":"Clin Transpl"},{"key":"B77","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/TP.0000000000000958","article-title":"One-Year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-Blind Randomized Placebo-Controlled Trial","volume":"100","author":"Sautenet","year":"2016","journal-title":"Transplantation"},{"key":"B78","doi-asserted-by":"publisher","first-page":"389","DOI":"10.34067\/kid.0001082019","article-title":"Short-Term Immunopathological Changes Associated With Pulse Steroids\/IVIG\/Rituximab Therapy in Late Kidney Allograft Antibody Mediated Rejection","volume":"1","author":"Degner","year":"2020","journal-title":"Kidney360"},{"key":"B79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.trre.2015.12.002","article-title":"Rabbit Antithymocyte Globulin and Donor-Specific Antibodies in Kidney Transplantation--A Review","volume":"30","author":"Pascual","year":"2016","journal-title":"Transpl Rev (Orlando)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1600-6143.2011.03554.x","article-title":"Targeting B Cells and Antibody in Transplantation","volume":"11","author":"Clatworthy","year":"2011","journal-title":"Am J Transplant"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMc1711335","article-title":"IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1111\/ajt.16754","article-title":"Outcomes at 3 Years Posttransplant in Imlifidase-Desensitized Kidney Transplant Patients","volume":"21","author":"Kjellman","year":"2021","journal-title":"Am J Transplant"},{"key":"B83","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.3389\/ti.2023.11244","article-title":"Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines","volume":"36","author":"Couzi","year":"2023","journal-title":"Transpl Int"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1681\/ASN.V10102208","article-title":"Complement Activation in Acute Humoral Renal Allograft Rejection: Diagnostic Significance of C4d Deposits in Peritubular Capillaries","volume":"10","author":"Collins","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.healun.2012.09.016","article-title":"Treatment of Hyperacute Antibody-Mediated Lung Allograft Rejection With Eculizumab","volume":"31","author":"Dawson","year":"2012","journal-title":"J Heart Lung Transpl"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1097\/TP.0000000000002165","article-title":"Acute Antibody-Mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab","volume":"102","author":"Muller","year":"2018","journal-title":"Transplantation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1111\/ajt.15175","article-title":"Long-Term Outcomes of Eculizumab-Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor-Specific Antibodies","volume":"19","author":"Schinstock","year":"2019","journal-title":"Am J Transpl"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.healun.2023.05.005","article-title":"Intermediate-Term Outcomes of Complement Inhibition for Prevention of Antibody-Mediated Rejection in Immunologically High-Risk Heart Allograft Recipients","volume":"42","author":"Coutance","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"B89","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/s0003-4975(01)03235-0","article-title":"C1-Esterase Inhibitor Reduces Reperfusion Injury After Lung Transplantation","volume":"73","author":"Scherer","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/TP.0000000000000034","article-title":"C1-Esterase-Inhibitor for Primary Graft Dysfunction in Lung Transplantation","volume":"97","author":"Sommer","year":"2014","journal-title":"Transplantation"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients","volume":"17","author":"Choi","year":"2017","journal-title":"Am J Transpl"},{"key":"B92","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/TP.0000000000002895","article-title":"Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-Mediated Rejection","volume":"104","author":"Shin","year":"2020","journal-title":"Transplantation"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.healun.2023.05.012","article-title":"Tocilizumab for Antibody-Mediated Rejection Treatment in Lung Transplantation","volume":"42","author":"January","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"B94","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.transci.2014.04.006","article-title":"ECP and Solid Organ Transplantation","volume":"50","author":"Jaksch","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/TP.0b013e31818bc024","article-title":"Extracorporeal Photopheresis After Lung Transplantation: A 10-Year Single-Center Experience","volume":"86","author":"Benden","year":"2008","journal-title":"Transplantation"},{"key":"B96","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000431382","article-title":"Long-Term Off-Line Extracorporeal Photochemotherapy in Patients With Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis","volume":"90","author":"Del Fante","year":"2015","journal-title":"Respiration"},{"key":"B97","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/ajt.12155","article-title":"Phenotyping Established Chronic Lung Allograft Dysfunction Predicts Extracorporeal Photopheresis Response in Lung Transplant Patients","volume":"13","author":"Greer","year":"2013","journal-title":"Am J Transpl"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13041","article-title":"Lung Transplant Recipients on Long-Term Extracorporeal Photopheresis","volume":"31","author":"Isenring","year":"2017","journal-title":"Clin Transpl"},{"key":"B99","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.healun.2012.05.002","article-title":"A Prospective Interventional Study on the Use of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation","volume":"31","author":"Jaksch","year":"2012","journal-title":"J Heart Lung Transpl"},{"key":"B100","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.resmer.2022.100913","article-title":"Initiation of Extracorporeal Photopheresis in Lung Transplant Patients With Mild to Moderate Refractory BOS: A Single-Center Real-Life Experience","volume":"81","author":"Leroux","year":"2022","journal-title":"Respir Med Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.healun.2009.08.029","article-title":"The Efficacy of Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation","volume":"29","author":"Morrell","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"B102","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.transproceed.2017.02.035","article-title":"Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation","volume":"49","author":"Pecoraro","year":"2017","journal-title":"Transpl Proc"},{"key":"B103","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.transproceed.2020.09.003","article-title":"Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience","volume":"53","author":"Vazirani","year":"2021","journal-title":"Transpl Proc"},{"key":"B104","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.healun.2022.09.022","article-title":"Assessing Treatment Outcomes in CLAD: The Hannover-Extracorporeal Photopheresis Model","volume":"42","author":"Greer","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"B105","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000508170","article-title":"Outcome of Extracorporeal Photopheresis as an Add-On Therapy for Antibody-Mediated Rejection in Lung Transplant Recipients","volume":"47","author":"Benazzo","year":"2020","journal-title":"Transfus Med Hemother"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12973\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:57:16Z","timestamp":1723006636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12973\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":105,"alternative-id":["10.3389\/ti.2024.12973"],"URL":"https:\/\/doi.org\/10.3389\/ti.2024.12973","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"article-number":"12973"}}